Can AI Infrastructure Demand Keep Driving FormFactor Stock Higher?

FormFactor (FORM) is positioned as AI infrastructure ramps up, driving record DRAM probe card revenue on strong HBM demand. The company expects another record quarter as customers transition from HBM3 to HBM4 (and toward HBM5), with SmartMatrix technology enabling simultaneous testing of hundreds of HBM stacks at HBM4 speeds. FORM raised its 2026 co-packaged optics (CPO) revenue outlook toward the high end of the prior $10–$20M range and projects demand across HBM, GPUs, networking, custom ASICs, and CPO to double revenue by 2030. Valuation remains rich (forward 12-month P/E 47.26x vs 24.98x for the sector) as Zacks Consensus 2026 earnings of $2.40 implies ~84.6% growth vs 2025.

Analysis

FORM’s edge is not just exposure to AI; it is leverage to the most test-intensive portion of the buildout, where every step-up in memory density raises content per wafer and slows qualification cycles. That creates a favorable revenue mix, but also a timing trap: the market is likely paying today for demand that only fully converts into shipments over the next 6-18 months. With the stock already re-rated aggressively, the main risk is not AI slowing, but the ramp being lumpy enough that the multiple de-rates before the earnings catch-up.

The more interesting second-order effect is competitive share capture across the test stack. If AI memory and advanced packaging stay hot, broader test vendors with installed base and throughput advantages can still win incremental wallet share even if FORM is the most direct HBM beneficiary. That argues for monitoring TER and COHU as relative beneficiaries of rising test complexity, especially if customers diversify suppliers to reduce bottlenecks. On the supply side, equipment and production-test partners tied to CPO could see small but strategic order flow, but this remains more of a design-win story than a near-term earnings driver.

Contrarian view: consensus is treating the 2030 growth narrative as more visible than it really is. The visible catalyst path is still dependent on HBM4 qualification, GPU volume timing, and whether CPO remains an engineering curiosity or becomes a real production line item. If any of those slip, a 40s forward multiple leaves little margin for error; if they execute cleanly, the upside is likely in estimate revisions more than further multiple expansion.

Key Decisions for Investors

• Long FORM on 3-6 month pullbacks, but only if the stock can hold above the post-rerating support zone; risk/reward is best as a momentum-with-fundamentals trade, not a blind chase.
• Use a relative-value pair: long FORM / short TER into any AI-test enthusiasm spike, betting that FORM’s narrower HBM/CPO exposure drives faster estimate upside while TER faces more mixed end-market debate. Reassess if TER’s AI bookings inflect meaningfully in the next print.
• Avoid paying up for FORM ahead of the next qualification milestone unless management confirms HBM4 ramp timing and 2H26 GPU shipment cadence; failure to do so would be a clear thesis break and likely catalyst for multiple compression.
• Watch TOELY and the broader semiconductor production-test ecosystem as a secondary beneficiary; if CPO ramps faster than expected, the cleaner trade may be on the equipment side rather than FORM’s already-expensive equity.
• Set an alert for any revenue guide miss or unchanged 2026 consensus after the next quarter; if estimates stop moving while the stock remains near peak multiples, take profits or hedge with short-dated calls against the long.